---
input_text: Electroacupuncture Improves Motor Symptoms of Parkinson's Disease and
  Promotes Neuronal Autophagy Activity in Mouse Brain. Autophagic defects are a hallmark
  of neurodegenerative disorders, such as Parkinson's disorder (PD). Enhancing autophagy
  to remove impaired mitochondria and toxic protein aggregation is an essential component
  of PD treatment. In particular, activation of autophagy confers neuroprotection
  in cellular and preclinical models of neurodegenerative diseases. In this study,
  we investigated the therapeutic mechanisms of electroacupuncture (EA) treatment
  in mice with established PD and evaluated the relationship between EA, autophagy,
  and different neurons in the mouse brain. We report that EA improves PD motor symptoms
  in mice and enhances (1) autophagy initiation (increased Beclin 1), (2) autophagosome
  biogenesis (increased Atg5, Atg7, Atg9A, Atg12, Atg16L, Atg3, and LC3-II), (3) autophagy
  flux/substrate degradation (decreased p62), and (4) mitophagy (increased PINK1 and
  DJ-1) in neurons of the substantia nigra, striatum, hippocampus, and cortex (affected
  brain areas of PD, Huntington disease, and Alzheimer's disease). EA enhances autophagy
  initiation, autophagosome biogenesis, mitophagy, and autophagy flux/substrate degradation
  in certain brain areas. Our findings are the first to show that EA regulates neuronal
  autophagy and suggest that this convenient, inexpensive treatment has exciting therapeutic
  potential in neurodegenerative disorders.
raw_completion_output: |-
  primary_disease: Parkinson's Disease

  medical_actions: Electroacupuncture; Enhancing autophagy

  symptoms: Motor symptoms

  chemicals: Beclin 1; Atg5; Atg7; Atg9A; Atg12; Atg16L; Atg3; LC3-II; p62; PINK1; DJ-1

  action_annotation_relationships: Electroacupuncture TREATS Motor symptoms IN Parkinson's Disease; Enhancing autophagy (with Beclin 1) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with Atg5) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with Atg7) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with Atg9A) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with Atg12) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with Atg16L) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with Atg3) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with LC3-II) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with p62) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with PINK1) PREVENTS autophagic defects IN Parkinson's Disease; Enhancing autophagy (with DJ-1) PREVENTS autophagic defects IN Parkinson's Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Enhancing autophagy (with DJ-1) PREVENTS autophagic defects IN Parkinson's Disease

  ===

extracted_object:
  primary_disease: MONDO:0005180
  medical_actions:
    - Electroacupuncture
    - Enhancing autophagy
  symptoms:
    - Motor symptoms
  chemicals:
    - Beclin 1
    - Atg5
    - Atg7
    - Atg9A
    - Atg12
    - Atg16L
    - Atg3
    - LC3-II
    - p62
    - PINK1
    - DJ-1
  action_annotation_relationships:
    - subject: Electroacupuncture
      predicate: TREATS
      object: Motor symptoms
      qualifier: MONDO:0005180
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Beclin 1
      subject_extension: Beclin 1
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Atg5
      subject_extension: Atg5
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Atg7
      subject_extension: Atg7
      object_extension: autophagic defects
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Atg9A
      subject_extension: Atg9A
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with
      subject_extension: Atg12
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Atg16L
      subject_extension: Atg16L
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Atg3
      subject_extension: Atg3
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with LC3-II
      subject_extension: LC3-II
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with p62
      subject_extension: p62
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with PINK1
      subject_extension: PINK1
    - subject: Enhancing autophagy
      predicate: PREVENTS
      object: autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with DJ-1
      subject_extension: DJ-1
named_entities:
  - id: MONDO:0007739
    label: Huntington Disease
  - id: CHEBI:16908
    label: NADH
  - id: HP:0002180
    label: neurodegeneration
  - id: MAXO:0001001
    label: gene therapies
  - id: MAXO:0000127
    label: genetic testing
  - id: MONDO:0020696
    label: Vitamin B12 Deficiency
  - id: MAXO:0000760
    label: Vitamin B12 supplementation
  - id: MAXO:0000427
    label: MRI of the brain
  - id: CHEBI:176843
    label: Vitamin B12
  - id: MONDO:0020380
    label: Spinocerebellar Ataxia (SCA)
  - id: HP:0001272
    label: Cerebellar atrophy
  - id: MONDO:0004975
    label: Alzheimer's disease
  - id: MONDO:0017276
    label: frontotemporal dementia
  - id: MONDO:0004976
    label: amyotrophic lateral sclerosis
  - id: MONDO:0007661
    label: Tourette Syndrome
  - id: HP:0002072
    label: Chorea
  - id: MONDO:0005071
    label: Neurological Disorders
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0012174
    label: glioblastoma
  - id: MONDO:0005109
    label: HIV
  - id: MONDO:0005559
    label: Neurodegenerative diseases
  - id: CHEBI:16243
    label: quercetin
  - id: CHEBI:3962
    label: curcumin
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:75095
    label: chrysin
  - id: CHEBI:28821
    label: piperine
  - id: CHEBI:17620
    label: ferulic acid
  - id: CHEBI:78330
    label: huperzine A
  - id: CHEBI:16118
    label: berberine
  - id: CHEBI:2979
    label: baicalein
  - id: CHEBI:28230
    label: hesperetin
  - id: CHEBI:26536
    label: retinoic acid
  - id: HP:0002015
    label: Dysphagia
  - id: CHEBI:50202
    label: Naringenin
  - id: CHEBI:16348
    label: 3-nitropropionic acid
  - id: CHEBI:28790
    label: Serotonin
  - id: HP:0000709
    label: psychosis
  - id: HP:0011951
    label: aspiration pneumonia
  - id: HP:0000716
    label: depression
  - id: MAXO:0000065
    label: aerobic exercises
  - id: MAXO:0000610
    label: enzyme-linked immunosorbent assays
  - id: CHEBI:53444
    label: potassium dichromate
  - id: CHEBI:141442
    label: Manganese (Mn)
  - id: HP:0100021
    label: Cerebral palsy
  - id: HP:0001915
    label: Aplastic anemia
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0000708
    label: behavioral problems
  - id: HP:0004421
    label: Elevated systolic blood pressure
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0005098
    label: stroke
  - id: MONDO:0005301
    label: multiple sclerosis
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:7872
    label: oxytocin
  - id: CHEBI:9937
    label: vasopressin
  - id: HP:0033429
    label: neuroinflammation
  - id: MAXO:0000016
    label: Cell Therapy
  - id: CHEBI:6437
    label: levetiracetam
  - id: MAXO:0000900
    label: Electrocardiograms (ECGs) collection
  - id: HP:0040141
    label: Tardive dyskinesia
  - id: MONDO:0010096
    label: tardive dyskinesia
  - id: HP:0005268
    label: Spontaneous abortion
  - id: CHEBI:16675
    label: quinolinic acid
  - id: MONDO:0001627
    label: Dementias
  - id: HP:0001300
    label: parkinsonism
  - id: CHEBI:76720
    label: antisense oligonucleotide
  - id: CHEBI:192545
    label: LY379268
  - id: HP:0005305
    label: cerebral venous thrombosis
  - id: HP:0001891
    label: iron-deficiency anemia
  - id: HP:0001875
    label: neutropenia
  - id: HP:0000657
    label: Ocular Motor Apraxia
  - id: HP:0025464
    label: Oxidative stress
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0002511
    label: Alzheimer's disease
  - id: HP:0001297
    label: Stroke
  - id: MAXO:0009004
    label: Exome sequencing
  - id: HP:0001251
    label: Ataxia
  - id: HP:0000726
    label: Dementia
  - id: HP:0001332
    label: Dystonia
  - id: HP:0002313
    label: Spastic paraparesis
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000137
    label: PET scan
  - id: HP:0000750
    label: Speech Difficulties
  - id: HP:0002446
    label: Astrogliosis
  - id: CHEBI:76931
    label: N-acetylaspartylglutamate
  - id: MONDO:0005395
    label: Movement disorders
  - id: HP:0100033
    label: Tic disorders
  - id: CHEBI:50114
    label: Oestrogens
  - id: CHEBI:50113
    label: Androgens
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0000943
    label: Deep brain stimulation (DBS)
  - id: CHEBI:15765
    label: Levodopa
  - id: MONDO:0024331
    label: Colorectal cancer (CRC)
  - id: MONDO:0005575
    label: Colorectal cancer
